microRNA Biomarkers as Potential Diagnostic Markers for Cancer - Genomic Biomarkers for Pharmaceutical Development - page 117

[61] Chaya C, Nealon WH, Bhutani MS. EUS or percutaneous CT / US-guided FNA for suspected pancreatic can-
cer: when tissue is the issue. Gastrointest Endosc 2006;63:976-8.
[62] Diehl SJ, Lehmann KJ, Sadick M, Lachmann R, Georgi M. Pancreatic cancer: value of dual-phase helical CT in
assessing resectability. Radiology 1998;206:373-8.
[63] Imbriaco M, Megibow AJ, Camera L, Pace L, Mainenti PP, Romano M, et al. Dual-phase versus single-phase
helical CT to detect and assess resectability of pancreatic carcinoma. Am J Roentgenol 2002;178:1473-9.
[64] Volmar KE, Vollmer RT, Jowell PS, Nelson RC, Xie HB. Pancreatic FNA in 1000 cases: a comparison of imag-
ing modalities. Gastrointest Endosc 2005;61:854-61.
[65] Maringhini A, Ciambra M, Raimondo M, Baccelliere P, Grasso R, Dardanoni G, et al. Clinical presentation
and ultrasonography in the diagnosis of pancreatic cancer. Pancreas 1993;8:146-50.
[66] Chen Y, Zheng B, Robbins DH, Lewin DN, Mikhitarian K, Graham A, et al. Accurate discrimination of pan-
creatic ductal adenocarcinoma and chronic pancreatitis using multimarker expression data and samples
obtained by minimally invasive ine needle aspiration. Int J Cancer 2007;120:1511-17.
[67] Eloubeidi MA, Jhala D, Chhieng DC, Chen VK, Eltoum I, Vickers S, et al. Yield of endoscopic ultrasound-
guided ine-needle aspiration biopsy in patients with suspected pancreatic carcinoma. Cancer 2003;99:285-92.
[68] Raut CP, Grau AM, Staerkel GA, Kaw M, Tamm EP, Wolff RA, et al. Diagnostic accuracy of endoscopic
ultrasound-guided ine-needle aspiration in patients with presumed pancreatic cancer. J Gastrointest Surg
2003;7:118-26; discussion 127-8.
[69] Agarwal B, Abu-Hamda E, Molke KL, Correa AM, Ho L. Endoscopic ultrasound-guided ine needle aspira-
tion and multidetector spiral CT in the diagnosis of pancreatic cancer. Am J Gastroenterol 2004;99:844-50.
[70] Taylor B. Carcinoma of the head of the pancreas versus chronic pancreatitis: diagnostic dilemma with signii-
cant consequences. World J Surg 2003;27:1249-57.
[71] Graham RA, Bankoff M, Hediger R, Shaker HZ, Reinhold RB. Fine-needle aspiration biopsy of pancreatic
ductal adenocarcinoma: loss of diagnostic accuracy with small tumors. J Surg Oncol 1994;55:92-4.
[72] Jhala NC, Jhala DN, Chhieng DC, Eloubeidi MA, Eltoum IA. Endoscopic ultrasound-guided ine-needle aspi-
ration. A cytopathologist's perspective. Am J Clin Pathol 2003;120:351-67.
[73] Zalatnai A. Pathologic diagnosis of pancreatic cancer - facts, pitfalls, challenges. Orv Hetil 2001;142:
1885-90.
[74] Shin HJ, Lahoti S, Sneige N. Endoscopic ultrasound-guided ine-needle aspiration in 179 cases: the M. D.
Anderson Cancer Center experience. Cancer 2002;96:174-80.
[75] Chang KJ, Katz KD, Durbin TE, Erickson RA, Butler JA, Lin F, et al. Endoscopic ultrasound-guided ine-nee-
dle aspiration. Gastrointest Endosc 1994;40:694-9.
[76] Laurell H, Bouisson M, Berthelemy P, Rochaix P, Dejean S, Besse P, et al. Identiication of biomarkers of
human pancreatic adenocarcinomas by expression proiling and validation with gene expression analysis in
endoscopic ultrasound-guided ine needle aspiration samples. World J Gastroenterol 2006;12:3344-51.
[77] van Gulik TM, Reeders JW, Bosma A, Moojen TM, Smits NJ, Allema JH, et al. Incidence and clinical ind-
ings of benign, inlammatory disease in patients resected for presumed pancreatic head cancer. Gastrointest
Endosc 1997;46:417-23.
[78] Ardengh JC, Lopes CV, Campos AD, Pereira de Lima LF, Venco F, Modena JL. Endoscopic ultrasound and
ine needle aspiration in chronic pancreatitis: differential diagnosis between pseudotumoral masses and pan-
creatic cancer. JOP 2007;8:413-21.
[79] Gudjonsson B, Livstone EM, Spiro HM. Cancer of the pancreas: diagnostic accuracy and survival statistics.
Cancer 1978;42:2494-506.
[80] Erickson RA. Pancreatic cancer. In: Balducci L, Talavera F, Movsas B, McKenna R, Macdonald JS, editors.
eMedicine from WebMD vol. 2007; 2005.
[81] Yachida S, Jones S, Bozic I, Antal T, Leary R, Fu B, et al. Distant metastasis occurs late during the genetic evo-
lution of pancreatic cancer. Nature 2010;467:1114-17.
[82] Howlader N, Noone A, Krapcho M, Neyman N, Aminou R, Waldron W, et al. SEER Cancer Statistics Review,
1975-2008 2011 edit. SEER. 2011.
[83] Gironella M, Seux M, Xie MJ, Cano C, Tomasini R, Gommeaux J, et al. Tumor protein 53-induced nuclear
protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc
Natl Acad Sci USA 2007;104:16170-16175.
[84] Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, et al. Transactivation of miR-
34a by p53 broadly inluences gene expression and promotes apoptosis. Mol Cell 2007;26:745-52.